Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Sci Rep. 2020 Mar 10;10(1):4418. doi: 10.1038/s41598-020-61459-4.
Lower corrected calcium (cCa) levels are associated with a better prognosis among incident dialysis patients. However, cCa frequently overestimates ionized calcium (iCa) levels. The prognostic importance of the true calcium status defined by iCa remains to be revealed. We conducted a retrospective cohort study of incident hemodialysis patients. We collected data of iCa levels immediately before the first dialysis. We divided patients into three categories: apparent hypocalcemia (low iCa; <1.15 mmol/L and low cCa; <8.4 mg/dL), hidden hypocalcemia (low iCa despite normal or high cCa), and normocalcemia (normal iCa). The primary outcome was the composite of all-cause death and cardiovascular diseases after hospital discharge. Among the enrolled 332 patients, 75% of the patients showed true hypocalcemia, defined as iCa <1.15 mmol/L, 61% of whom showed hidden hypocalcemia. In multivariate Cox models including other potential risk factors, true hypocalcemia was a significant risk factor (hazard ratio [HR], 2.34; 95% confidence interval [CI], 1.03-5.34), whereas hypocalcemia defined as corrected calcium <8.4 mg/dL was not. Furthermore, hidden hypocalcemia was significantly associated with an increased risk of the outcome compared with normocalcemia (HR, 2.56; 95% CI, 1.11-5.94), while apparent hypocalcemia was not. Patients with hidden hypocalcemia were less likely to receive interventions to correct hypocalcemia, such as increased doses of active vitamin D or administration of calcium carbonate, than patients with apparent hypocalcemia (odds ratio, 0.45; 95% CI, 0.23-0.89). Hidden hypocalcemia was a strong predictor of death and cardiovascular events, suggesting the importance of measuring iCa.
血钙校正值较低与新透析患者的预后较好相关。然而,校正钙通常会高估离子钙水平。离子钙定义的真正钙状态的预后意义仍有待揭示。我们对新开始血液透析的患者进行了回顾性队列研究。我们收集了首次透析前的离子钙水平数据。我们将患者分为三组:明显低钙血症(低离子钙;<1.15mmol/L 和低校正钙;<8.4mg/dL)、隐匿性低钙血症(低离子钙但校正钙正常或升高)和正常钙血症(正常离子钙)。主要结局是出院后全因死亡和心血管疾病的复合事件。在纳入的 332 名患者中,75%的患者存在真正的低钙血症,定义为离子钙<1.15mmol/L,其中 61%的患者存在隐匿性低钙血症。在包括其他潜在风险因素的多变量 Cox 模型中,真正的低钙血症是一个显著的风险因素(风险比 [HR],2.34;95%置信区间 [CI],1.03-5.34),而校正钙<8.4mg/dL 的低钙血症不是。此外,与正常钙血症相比,隐匿性低钙血症与结局风险增加显著相关(HR,2.56;95%CI,1.11-5.94),而明显低钙血症则不然。与明显低钙血症患者相比,隐匿性低钙血症患者接受纠正低钙血症干预的可能性较小,例如增加活性维生素 D 剂量或碳酸钙给药(比值比,0.45;95%CI,0.23-0.89)。隐匿性低钙血症是死亡和心血管事件的强烈预测因素,提示测量离子钙的重要性。